Finance

Beta
Lists
CCEL:NYSEAMERICAN
Cryo-Cell International Inc
$3.37
-6.91%
(-0.25) 1D
May 29, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CCEL...
Open
$3.33
High
$3.50
Low
$2.97
Mkt. cap
27.15M
Avg. vol.
9.40K
Volume
8.18K
52-wk high
$6.35
52-wk low
$2.72
EPS
-$0.33
Beta
0.08
Shares outstanding
8.06M
No. of employees
74
Open
$3.33
High
$3.50
Low
$2.97
Mkt. cap
27.15M
Avg. vol.
9.40K
Volume
8.18K
52-wk high
$6.35
52-wk low
$2.72
EPS
-$0.33
Beta
0.08
Shares outstanding
8.06M
No. of employees
74
News stories
From sources across the web
Profile
Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL. Wikipedia
About Cryo-Cell International Inc
CEOMark L. Portnoy | David I. Portnoy
Employees74
Founded1989
HeadquartersOldsmar, Florida, United States
SectorHealth care provider
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
May 2025
Aug 2025
Nov 2025
Feb 2026
Revenue
7.93M
7.83M
7.84M
7.68M
Cost of goods sold
1.86M
1.80M
6.09M
1.66M
Cost of revenue
1.86M
1.80M
6.09M
1.66M
Research and development expenses
131.71K
61.62K
84.78K
65.76K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.26M
3.88M
5.45M
5.01M
Operating expense
4.58M
4.12M
5.72M
5.26M
Total operating expenses
6.44M
5.92M
11.81M
6.92M
Operating income
1.49M
1.90M
-3.97M
765.13K
Other non operating income
12.93K
17.56K
18.41K
8.34K
EBT including unusual items
575.10K
1.19M
-4.63M
70.31K
EBT excluding unusual items
954.44K
1.38M
-4.43M
310.77K
Income tax expense
219.32K
436.59K
-814.54K
23.20K
Effective tax rate
38.14%
36.81%
17.59%
33.00%
Other operating expenses
-
-
-
-
Net income
355.78K
749.41K
-3.82M
47.11K
Net profit margin
4.49%
9.58%
-48.67%
0.61%
Earnings per share
0.05
0.10
-0.47
0.02
Interest and investment income
-
-
-
-
Interest expense
-551.13K
-538.22K
-481.95K
-462.71K
Net interest expenses
-551.13K
-538.22K
-481.95K
-462.71K
Depreciation and amortization charges
190.10K
185.69K
183.83K
183.89K
EBITDA
1.74M
2.14M
-3.72M
1.01M
Gain or loss from assets sale
47.67K
633.00
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more